IL1B and triple-negative breast carcinoma: Consistently, in an experimental model of triple-negative breast cancer, IL-1β deficient mice revealed significantly reduced levels of macrophages in the primary tumors, which were associated with limited tumor growth and an increase in infiltrating CD8+ T cells [3].